OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)Director sold ~$297K

Ellen M Zane, Director at Boston Scientific, sold ~$297K of Boston Scientific shares.

~$297K
Approx. value · 2,901 sh @ $102.24
24K
Holds after · shares reported
Traded
Oct 28, 2025
Filed
Oct 28, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  2. Aug 4, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  3. Sep 2, 2025Insider · 1 personInsiders: 2 sales (~$5.3M)
  4. Sep 23, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  5. Sep 26, 2025FDAFDA device clearance: Radial Jaw 4 Pulmonary Biopsy Forceps
  6. Oct 9, 2025FDAFDA device clearance: Orca Air/Water and Suction Valves
  7. Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  8. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
  9. Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
  10. Oct 27, 2025InsiderDirector sold ~$1.01M of BSX shares in the open market
  11. Oct 28, 2025 · this disclosureInsiderDirector sold ~$297K of BSX shares in the open market

What came next

  1. Oct 28, 2025FDAFDA device clearance: TheraSphere 360™ Y-90 Management Platform
  2. Oct 28, 2025CongressDisclosed partial sale of BSX — reported range $15,001 - $50,000
  3. Oct 30, 2025FDAFDA device clearance: Moses™ 200 D/F/L Laser Fiber (M0068130100); Moses™ 365 D/F/L Laser Fiber (M0068130110); Moses™ 550 D/F/L Laser Fiber (M0068130120)
  4. Oct 30, 2025FDAFDA device clearance: OBSIDIO™ Conformable Embolic (M0013972101010)
  5. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  6. Oct 31, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  7. Nov 3, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
  8. Nov 6, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
  9. Nov 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 18, 2025, upon the recommendation of the Executive Compensation and Human Resources Committee (the “Compensation Committee”), the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) approved the Company’s 2026 Annual Bonus Plan effective for the performance year of January 1, 2026 through December 31, 2026 (the “2026 Annual Bonus Plan”).”
  10. Nov 18, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  11. Dec 1, 2025InsiderOfficer sold ~$1.76M of BSX shares in the open market
  12. Dec 3, 2025FDARecall: Boston Scientific Coyote OVER-THE-WIRE PTA Balloon Dilation Catheter, 4F, 1) 2.5mm x120mm, 150 cm, UPM/Model No. REF H74939186251210; 2) 3.5mm x120mm, 150 cm,…
  13. Dec 16, 2025Federal contract · $519K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $519K obligated to date
  14. Dec 17, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  15. Dec 19, 2025FDARecall: HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 6mm x 8mm; Material Number (UPN): M00553520;
  16. Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 20mm x 10mm; Material Number (UPN): M00553660;
  17. Dec 19, 2025FDARecall: *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 20mm x 10mm; Material Number (UPN): M00553560;
  18. Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 6mm x 8mm; Material Number (UPN): M00553680;
  19. Dec 19, 2025FDARecall: *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 8mm x 8mm; Material Number (UPN): M00553530;
  20. Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 8mm x 8mm; Material Number (UPN): M00553690;
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Ellen M Zane, Director

The full history of Ellen M Zane, Director is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data